Elevate your local knowledge

Sign up for the iNFOnews newsletter today!

Select Region

Selecting your primary region ensures you get the stories that matter to you first.

AP source: Johnson & Johnson to pay over $2.2B to resolve allegations on drug labeling

CP25803233
Attorney General Eric Holder speaks about a Justice Department settlement with Johnson & Johnson during a news conference at the Department of Justice in Washington, Monday, Nov. 4, 2013. Johnson & Johnson and its subsidiaries have agreed to pay over .2 billion to resolve criminal and civil allegations of promoting three prescription drugs for off-label uses not approved by the Food and Drug Administration.. (AP Photo/Manuel Balce Ceneta)

WASHINGTON – A federal law enforcement official says Johnson & Johnson and its subsidiaries have agreed to pay over $2.2 billion to resolve criminal and civil allegations of promoting three prescription drugs for off-label uses not approved by the Food and Drug Administration.

The official also says the allegations include paying kickbacks to physicians and pharmacies to recommend and prescribe Risperdal and Invega, both antipsychotic drugs, and Natrecor, which is used to treat heart failure.

The official spoke on condition of anonymity because the source was not authorized to speak publicly about the matter.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles